Background illustration for clinical trials search

Paid Clinical Trials New Haven

Discover 1,147 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

for
Solid Tumors (Phase 1)
Location: New Haven CT, Springdale AR, Houston TX
Sponsor: Adcendo ApS

Sex: All

Age: 18+

Code: NCT07362888

Phase1, Recruiting

Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

for
Multiple Myeloma
Location: New Haven CT
Sponsor: Noffar Bar

Sex: All

Age: 18+

Code: NCT06993675

Phase2, Recruiting

Merck IIT: RRP Pembro and Lenvatinib

for
Human Papilloma Virus, Recurrent Respiratory Papillomatosis,
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT04645602

Phase2, Recruiting

AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

for
Advanced Melanoma and Normal or Impaired, Advanced Melanoma
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07027488

Phase1, Recruiting

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: New Haven CT, Derby CT, Guilford CT, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06649812

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

tDCS for Laryngeal Dystonia

for
Laryngeal Dystonia
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 65

Code: NCT06830174

Recruiting

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

for
Malignant Glioma
Location: New Haven CT, Hartford CT, New Hyde Park NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 21

Code: NCT05099003

Phase1, Phase2, Recruiting

Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy

for
HER2 Negative Breast Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06953882

Phase2, Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

for
Metastatic Colorectal Cancer
Location: New Haven CT, Cleveland OH, Grand Rapids MI, Houston TX
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07079631

Phase1, Phase2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: New Haven CT, Stony Brook NY, Hartford CT, Valhalla NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: New Haven CT, Hartford CT, New Hyde Park NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase2, Recruiting

Circulating Tumor DNA

for
ER+ Breast Cancer
Location: New Haven CT, The Bronx NY, Boston MA, Baltimore MD,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06923527

Phase2, Recruiting

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

for
Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases
Location: New Haven CT, West Haven CT, Manhasset NY, The Bronx NY,
Sponsor: Duke University

Sex: All

Age: 70+

Code: NCT04262206

Recruiting

Home-based Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for IBS Pain

for
Pain, Chronic, Irritable Bowel Syndrome, Symptom Cluster
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 29

Code: NCT06847360

Recruiting

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: New Haven CT, The Bronx NY, Hackensack NJ, Brooklyn NY,
Sponsor: Children's Oncology Group

Sex: All

Age: 15 - 20

Code: NCT06410209

Phase2, Recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

for
Systemic Sclerosis, Scleroderma, Interstitial Lung Diseases
Location: New Haven CT, New York NY, Rochester NY, Durham NC,
Sponsor: Cabaletta Bio

Sex: All

Age: 18 - 70+

Code: NCT06328777

Phase2, Phase3, Recruiting

Alcohol-ROC-Training

for
Binge Drinking, Heavy Drinking, Young Adult, Heavy Drinker
Location: New Haven CT, Berkeley CA
Sponsor: Yale University

Sex: All

Age: 18 - 26

Code: NCT05491551

Recruiting

Hyperfractionated Dual Equivalent Fractionated Radiation Therapy

for
Diffuse Large B-Cell Lymphoma
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06898905

Recruiting

SELUTION4BTK Trial

for
Peripheral Arterial Disease,
Location: New Haven CT, Darien CT, New York NY, Providence RI,
Sponsor: M.A. Med Alliance S.A.

Sex: All

Age: 18+

Code: NCT05055297

Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: New Haven CT, Guilford CT, Mount Kisco NY, Bay Shore NY,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting